¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"chronic active photosensitive dermatitis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • active gradient shielding
    ´Éµ¿°æ»çÂ÷Æó
  • active hyperemia
    ´Éµ¿ÃæÇ÷
  • active imagination
    Àû±Ø»ó»ó, Àû±Ø¸í»ó
  • active immunity
    ´Éµ¿¸é¿ª
  • active immunization
    ´Éµ¿¸é¿ªÈ­
  • active incorporative mode
    Àû±ØÇÔÀÔ¾ç½Ä
  • active marrow
    Ȱ¼º°ñ¼ö
  • active material
    Ȱ¼º¹°Áú, Ȱ¼ºÀç
  • active movement
    ´Éµ¿¿îµ¿
  • active negativism
    Àû±Ø°ÅºÎÁõ
  • active oxygen
    Ȱµ¿»ê¼Ò, Ȱ¼º»ê¼Ò
  • active phase
    Ȱ¼º±â
  • active placebo
    Ȱ¼º¼ÓÀÓ¾à
  • active prosthesis
    Ȱµ¿ÀÇÁö, ´Éµ¿ÀÇÁö
  • active shielding
    ´Éµ¿Â÷Æó
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • active oxygen
    Ȱµ¿»ê¼Ò, Ȱ¼º»ê¼Ò
  • active placebo
    ¾ç¼º¼ÓÀÓ¾à
  • active prosthesis
    Ȱµ¿ÀÇÁö, ´Éµ¿ÀÇÁö
  • active shielding
    ´Éµ¿°¡¸², ´Éµ¿Â÷Æó
  • active shimming
    ´Éµ¿º¸Á¤
  • active site
    Ȱ¼ººÎÀ§
  • active transport
    ´Éµ¿¿î¹Ý
  • active treatment
    Àû±ØÄ¡·á
  • active tuberculosis
    Ȱµ¿°áÇÙ
  • active gradient shielding
    ´Éµ¿±â¿ï±âÂ÷Æó, ´Éµ¿°æ»çÂ÷Æó
  • active incorporative mode
    Àû±ØÇÔÀÔ¾ç½Ä
  • artificial active immunity
    Àΰø´Éµ¿¸é¿ª
  • surface-active disinfectant
    Ç¥¸éȰ¼º¼Òµ¶Á¦, °è¸éȰ¼º¼Òµ¶Á¦
  • metabolically active stone
    ´ë»çȰ¼ºµ¹
  • MR active nuclei
    ÀÚ±â°ø¸íȰ¼ºÇÙ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • active material
    Ȱ¼º¹°Áú(üÀàõÚªòõ).
  • active movement
    ´Éµ¿¿îµ¿(ÒöÔÑê¡ÔÑ)
  • active negativism
    Àû±Ø¼º °ÅÀýÁõ.
  • active oxygen
    Ȱ¼º»ê¼Ò(üÀàõß«áÈ).
  • active shielding
    ´Éµ¿ Â÷Æó
  • active shimming
    ´Éµ¿ º¸Á¤
  • active site
    Ȱ¼ºÀÚ¸®.
  • active spot
    Ȱ¼ºÁ¡(üÀàõïÇ).
  • active tension
    ´Éµ¿Àå·Â(ÒöÔÑíåæ³)
  • active transport
    ´Éµ¿(Àû)¿î¹Ý(¡­îÜê¡Úæ), ´Éµ¿(Àû)¼ö¼Û(ÒöÔÑîÜâÃáê)
  • active treatment
    Á÷Á¢Ä¡·á, Àû±Ø¿ä¹ý(îÝпèþÛö).
  • active tuberculosis
    Ȱµ¿¼º °áÇÙ(Áõ)(üÀÔÑàõÌ¿ú·ñø).
  • artificial active immunity
    Àΰø´Éµ¿¸é¿ª.
  • immunization, active
    ´Éµ¿¸é¿ª, ´Éµ¿¸é¿ªÁ¶Ä¡
  • positive placebo =active p.
    ¾ç¼ºÇö󼼺¸, Ç¥Áؾà(øöñÞå·).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • active incorporative mode
    Àû±ØÀû ÇÔÀÔ ¾ç½Ä
  • active marrow
    Àû°ñ¼ö.
  • active material
    Ȱ¼º¹°Áú(üÀàõÚªòõ).
  • active movement
    ´Éµ¿¿îµ¿(ÒöÔÑê¡ÔÑ)
  • active negativism
    Àû±Ø¼º °ÅÀýÁõ.
  • active oxygen
    Ȱ¼º»ê¼Ò(üÀàõß«áÈ).
  • active shielding
    ´Éµ¿ Â÷Æó
  • active shimming
    ´Éµ¿ º¸Á¤
  • active site
    Ȱ¼ºÀÚ¸®.
  • active spot
    Ȱ¼ºÁ¡(üÀàõïÇ).
  • active tension
    ´Éµ¿Àå·Â(ÒöÔÑíåæ³)
  • active transport
    ´Éµ¿(Àû)¿î¹Ý(¡­îÜê¡Úæ), ´Éµ¿(Àû)¼ö¼Û(ÒöÔÑîÜâÃáê)
  • active treatment
    Á÷Á¢Ä¡·á, Àû±Ø¿ä¹ý(îÝпèþÛö).
  • active tuberculosis
    Ȱµ¿¼º °áÇÙ(Áõ)(üÀÔÑàõÌ¿ú·ñø).
  • artificial active immunity
    Àΰø´Éµ¿¸é¿ª.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • active phosphate
    Ȱ¼ºÀλ꿰 (üÀàõ ×òß«ç¤)
  • active phospholipid
    Ȱ¼ºÀÎÁöÁú (üÀàõ×òò·òõ)
  • active pyrophosphate
    Ȱ¼º(üÀàõ)ÇÇ·ÎÀλ꿰 (×òß«ç¤)
  • active pyruvate
    Ȱ¼º(üÀàõ)ÆÄÀÌ·çºê»ê¿° (ß«ç¤)
  • active site
    Ȱ¼º(üÀàõ)ÀÚ¸®
  • active site-directed irreversible inhibitor
    Ȱ¼º(üÀàõ)ÀÚ¸®ÁöÇâÀû ºÒ°¡¿ªÀúÇØÁ¦(ò¦ú¾îÜÝÕʦæ½îÁúªð¥)
  • active sulfate
    Ȱ¼ºÈ²»ê¿° (üÀàõüÜß«ç¤)
  • active translocation
    Ȱ¼ºÀüÀ§ (üÀàõï®êÈ)
  • active transport
    ´Éµ¿¼ö¼Û (ÒöÔÑâÃáê)
  • flexible active site
    °¡º¯(ʦܨ) Ȱ¼º(üÀàõ)ÀÚ¸®
  • gradient-coupled active transport
    ±¸¹è(ÎþÛÕ) ¦Áø ´Éµ¿¼ö¼Û(ÒöÔÑâÃáê)
  • primary active transport
    ÀÏÂ÷ ´Éµ¿¼ö¼Û(ìéó­ÒöÔÑâÃáê)
  • secondary active transport
    ÀÌÂ÷ ´Éµ¿¼ö¼Û(ì£ó­ÒöÔÑâÃáê)
  • surface-active agent
    Ç¥¸éȰ¼ºÁ¦ (øúØüüÀàõð¥)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
CPH Certificate in Public Health; chronic paroxysmal hemicrania; chronic persistent hepatitis; chronic p...
CAH   1) Chronic Active Hepatitis
  2) Congenital Adrenal Hyperplasia
A-CAH autoimmune chronic active hepatitis
ACH acetylcholine; achalasia; active chronic hepatitis; adrenocortical hormone; amyotrophic cerebellar h...
AI-CAH autoimmune-type chronic active hepatitis
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
PDD Papillomatous digital dermatitis
SD Seborrheic dermatitis
A Active
AS Active Sleep
A.S.I. Active Specific Immunotherapy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • artificial dermatitis
    Àΰø ÇǺο°
  • atopic dermatitis
    ¾ÆÅäÇÇ ÇǺο°, Áö·ç¼º ÇǺο°
    ¾ÆÅäÇÇ Ã¼ÁúÀÎ »ç¶÷¿¡°Ô »ý±â´Â ½ÀÁø ¸ð¾çÀÇ ÇǺΠº´º¯ÀÌ´Ù. ³»Àμº ½ÀÁø, º£´Ï¿¡¾ç ÁøÀ̶ó°íµµ ÇÑ´Ù. À¯ÀüÀûÀÎ °æÇâÀÌ ÀÖÀ¸³ª ¿øÀÎÀº ºÒ¸íÀÌ´Ù. º¸ÅëÀÇ ½ÀÁøÀ̳ª ÇǺο°°ú´Â ´Þ¸® ƯÀÌÇÑ Áõ¼¼¿Í °æ°ú¸¦ ³ªÅ¸³½´Ù. ¼Ò¾Æ ½ÀÁøÀÇ 70¡­80 %´Â ÀÌ ½ÀÁøÀÌ´Ù. ¿¬·É¿¡ µû¶ó Áõ¼¼ÀÇ º¯ÃµÀÌ ÀÖÀ¸¸ç, º¸Åë 3±â·Î ³ª´«´Ù. ¨ç À¯¾Æ±â
  • autoimmune progesterone dermatitis
    ÀÚ°¡ ¸é¿ª ÇÁ·Î°Ô½ºÅ×·Ð ÇǺο°
  • autosensitization dermatitis
    ÀÚ°¡ °¨ÀÛ ÇǺο°
  • beryllium dermatitis
    º£¸±·ý ÇǺο°
  • bleach dermatitis
    Ç¥¹é ÇǺο°
  • contact dermatitis
    Á¢Ã˼º ÇǺο°, Á¢ÃË ÇǺο°
    ¿ÜºÎÀÇ ¹°Áú¿¡ Á¢ÃËÇÔÀ¸·Î½á ÀϾ´Â ÇǺÎÀÇ ¿°ÁõÀÌ´Ù. À̸¥¹Ù ÇǺΰ¡ Çã´Â °ÍÀ¸·Î °¡·Á¿òÀÌ Æ¯Â¡ÀÌ´Ù. ±Þ¼º ½ÀÁø°ú °°Àº Áõ¼¼¸¦ ¶ìÁö¸¸, ¿ÜºÎ¿¡¼­ ÀÛ¿ëÇϴ ƯÁ¤ÀÇ ¹°Áú¿¡ ´ëÇÑ ¹ÝÀÀÀ¸·Î¼­ ÀϾ´Â Á¡ÀÌ ½ÀÁø°ú ´Ù¸£´Ù. ¹ßº´Çϱ⠽¬¿î ¹°Áú·Î´Â ¿Ì³ª¹«, °Ë¾ç ¿Ì³ª¹«, ¹«È­°ú³ª¹«, ÀºÇ೪¹« µîÀ» ºñ·ÔÇÏ¿©, µµ·á, ÇÕ¼º ¼öÁö Á¦Ç°, ÇÇÇõ Á¦Ç°, °í¹« Á¦Ç°, Å©·Ò µµ±Ý, ¾àǰ, È­Àåǰ·ù ¹× ÇÕ¼º ¼¶À¯·Î ¸¸µç ¼Ó¿Ê µîÀ» µé ¼ö ÀÖ´Ù.
  • dermatitis
    ÇǺο°
    1. ÇǺÎÀÇ ¿°Áõ. ½ÀÁø¼º º¯È­¸¦ º¸ÀÌ´Â °Í Áß ¿ÜÀο¡ ±âÀÎÇÏ´Â °ÍÀ» ÇǺο°À̶ó ÇÏ¸ç ³»Àο¡ ±âÀÎÇÏ´Â °ÍÀ» ½ÀÁøÀ̶ó°í ÇÏ´Â °Íµµ ÀÖ´Ù. ±×·¯³ª ½ÇÁ¦·Î´Â ¿ÜÀÎ, ³»ÀÎÀÇ ¾î´À ÂÊÀ» Áß½ÃÇϴ°¡ ÇÏ´Â ÆÇ´ÜÀº ½±Áö ¾ÊÀ¸¸ç ÀϹÝÀûÀ¸·Î ÇǺο°°ú ½ÀÁøÀº µ¿ÀǾî·Î¼­ »ç¿ëµÇ´Â °æ¿ì°¡ ¸¹´Ù. 2. º¸Åë ½ÀÁø
  • dermatitis artefacta
    °¡¼º ÇǺο°, Àΰø ÇǺο°
    ¿­, È­ÇÐ ¾àǰ, ±âŸ ¹°¸®Àû ¶Ç´Â ±â°èÀû ¹æ¹ý¿¡ ÀÇÇÏ¿© ȯÀÚ°¡ ÀÚÃÊÇÑ º´¼Ò¸¦ Ư¡À¸·Î ÇÏ´Â ÇǺÎÀÇ ¿°Áõ.
  • dermatitis exfoliativa neonatorum
    ½Å»ý¾Æ ¹Ú¶ô¼º ÇǺο°
    ½Å»ý¾ÆÀÇ ³ó°¡Áø¿¡ °è¼ÓÇÏ¿© ¹ß»ýÇÏ´Â ¹Ú¶ô¼º ÇǺο°. Áßµ¶¼º ±«»çÁõ°ú µ¿ÀÏÇÑ °ÍÀ¸·Î »ý°¢µÈ´Ù. Æ÷µµ»ó ±ÕÀÇ
  • dermatitis herpetiformis
    Æ÷Áø¼º ÇǺο°
    1. ¹«¸®¸¦ ÀÌ·ç°í ÀÖÀ¸¸ç ´ëĪÀûÀÎ È«¹Ý¼º, ±¸Áø¼º, ¼Ò¼öÆ÷¼º, ½ÀÁø¼º, ¼öÆ÷¼º µîÀÇ º´¼Ò¸¦ Ư¡À¸·Î ÇÏ´Â ¸¸¼º ÇǺο°. À§ÀÇ Áõ»óÀÌ ¿¬¼ÓÀûÀ¸·Î ³ªÅ¸³ª¸ç ÀÛ¿­°¨°ú °¡·Á¿òÀÌ ¼ö¹ÝµÈ´Ù. 2. ÇǺγª Á¡¸·¿¡ ´ëÇÑ ÀÚ°¡ Ç×ü¸¦ °¡ÁöÁö´Â ¾ÊÀ¸³ª Ç¥ÇÇÇÏ ¼öÆ÷¸¦ Çü¼ºÇϸç ÁøÇÇ¿Í Ç¥ÇÇÀÇ °æ°èºÎ¿¡ IgA°¡ Ä§ÂøµÇ°í ½ÉÇÑ ¼Ò¾ç°¨À» °¡Áö´Â ¸¸¼º ¼öÆ÷¼º ÁúȯÀÌ´Ù. ÇǺΠº´º¯Àº ÈçÈ÷ ÀÛÀº ¼öÆ÷·Î ³ªÅ¸³ª³ª È«¹Ý¼º ±¸Áø ¶Ç´Â µÎµå·¯±âÀÇ ÆÇÀ» º¸ÀÏ ¶§µµ ÀÖ´Ù. ´ë°³ µÎÇÇ, °æºÎ, µÐºÎ, ½½°³ºÎ³ª ÆÈ²ÞÄ¡ µî¿¡ È£¹ßÇϰí Á¡¸·¿¡´Â °ÅÀÇ ¹ß»ýÇÏÁö ¾Ê´Â´Ù.
  • dermatitis seborrheica
    Áö·ç¼º ÇǺο°
    º´ÀÎ ºÒ¸íÀÇ ¸¸¼º ¿°Áõ¼º ÇǺκ´. ÁߵÀÇ È«¹Ý, °Ç¼º, ½À¼º ¶Ç´Â ±â¸§ÀÌ ÀÖ´Â Àμ³ Çü¼º, Ȳ»öÀÇ °¡ÇǹÝÀ» Ư¡À¸·Î ¾È¸é Áß¾ÓºÎ, ±Í, ¾È¿Í ºÎÀ§, ¹è²Å, »ý½Ä±â ±×¸®°í ƯÈ÷ µÎÇǸ¦ Æ÷ÇÔÇÑ ¿©·¯ °÷¿¡ ¹ß»ýÇÑ´Ù. µÎÇÇ¿¡ À־´Â µÎÇÇ Àü¿ª¿¡±îÁö ÁøÇàÇÏ´Â Àμ³ÀÇ ÀÛÀº ¹ÝÀÌ ³ªÅ¸³­´Ù. ´ë·®ÀÇ °Ç¼º Àμ³ÀÇ ¹ÚÅ»À» ¼ö¹ÝÇϸç, Áõ»óÀº º¸Åë °¡·Á¿òÀ» ¼ö¹ÝÇÑ´Ù.
  • dust dermatitis
    ¸ÕÁö ÇǺο°
  • mercurial dermatitis
    ¼öÀº ÇǺο°
  • moth dermatitis
    ³ª¹æ ÇǺο°
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
active psychoanalysis Psychoanalysis in which the analyst intervenes directly and actively in the patient's life, e.g., by making prohibitions, assigning tasks.
(05 Mar 2000)
active pyruvate An intermediate formed in the oxidative decarboxylation of pyruvate.
Compare: pyruvate dehydrogenase (lipoamide).
Synonym: alpha-lactyl-thiamin pyrophosphate.
(05 Mar 2000)
active repressor A repressor that combines directly with an operator gene to repress the operator and its structural genes, thus repressing protein synthesis; active repressor may be repressed by an inducer, with resulting protein synthesis; a homeostatic mechanism for regulation of inducible enzyme systems.
(05 Mar 2000)
active site <chemistry> A specific region of an enzyme where a substrate binds and catalysis takes place (binding site).
(06 May 1997)
active splint A splint utilizing springs or elastic bands that aids in movements initiated by the patient by controlling the plane and range of motion.
Synonym: active splint, functional splint.
(05 Mar 2000)
active succinate The condensation product of succinic acid and CoA; one of the intermediates of the tricarboxylic acid cycle and a precursor in the synthesis of haem.
Synonym: active succinate, succinyl-CoA.
(05 Mar 2000)
active sulfate 3'-phosphoadenosine 5'-phosphosulfate;an intermediate in the formation of urinary ethereal sulfates, notable for containing a "high energy" sulfate bond; the 3'-OH of adenosine is replaced by -OPO3H2, the 5'-OH by -OP(O2H)-OSO3H.
Synonym: active sulfate.
Acronym: PAPS
(05 Mar 2000)
active transport <biochemistry, chemistry> Transport of ions, nutrients or other molecules into a cell against a concentration gradient, this requires the expenditure of energy through ATP hydrolysis.
(06 May 1997)
active treatment A therapeutic substance or course intended to ameliorate the basic disease problem, as opposed to supportive or palliative treatment.
Compare: causal treatment.
(05 Mar 2000)
active vasoconstriction Reduced caliber of a vessel caused by increased tonus in the smooth muscle in its walls.
(05 Mar 2000)
active vasodilation Vasodilation caused by decrease in tonus of smooth muscle in the wall of a vessel.
(05 Mar 2000)
artificial active immunity See: acquired immunity.
(05 Mar 2000)
biological transport, active The movement of materials across cell membranes and epithelial layers against an electrochemical gradient, requiring the expenditure of metabolic energy.
(12 Dec 1998)
specific active immunity See: acquired immunity.
(05 Mar 2000)
surface-active Indicating the property of certain agents of altering the physicochemical nature of surfaces and interfaces, bringing about lowering of interfacial tension; they usually possess both lipophilic and hydrophilic groups.
See: surfactant.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á